92 related articles for article (PubMed ID: 6192343)
1. Neutralizing site of poliovirus.
Brown F
Nature; 1983 Aug 4-10; 304(5925):395-6. PubMed ID: 6192343
[No Abstract] [Full Text] [Related]
2. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
Evans DM; Minor PD; Schild GS; Almond JW
Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
4. Persistence and class-specificity of neutralizing antibody response induced by trypsin-cleaved type 3 poliovirus in mice.
Roivainen M; Piirainen L; Hovi T
Vaccine; 1993; 11(7):713-7. PubMed ID: 7688171
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of virus-antibody immune complexes (poliovirus type I): Characterization of the epitopes in 3D.
Bannwarth L; Girerd-Chambaz Y; Arteni AA; Guigner JM; Lemains J; Ronzon F; Manin C; Vénien-Bryan C
Mol Immunol; 2015 Feb; 63(2):279-86. PubMed ID: 25146483
[TBL] [Abstract][Full Text] [Related]
6. Antigenic structure of poliovirus in inactivated vaccines.
Ferguson M; Wood DJ; Minor PD
J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
[TBL] [Abstract][Full Text] [Related]
7. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
Gu FZ; Wang SH; Sun YY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
[TBL] [Abstract][Full Text] [Related]
9. Antigen chimaeras of poliovirus as potential new vaccines.
Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
[TBL] [Abstract][Full Text] [Related]
10. Vaccines based on recombinant antigen strategies.
Minor P
Dev Biol (Basel); 2001; 105():189-94. PubMed ID: 11763327
[No Abstract] [Full Text] [Related]
11. Antigenic hybrids of poliovirus.
Hogle JM
Nature; 1988 Mar; 332(6159):13-4. PubMed ID: 2831454
[No Abstract] [Full Text] [Related]
12. Electron microscopic examination of the reactivity of three kinds of neutralizing antibodies with H particles of poliovirus.
Taniguchi K; Urasawa S; Urasawa T
Microbiol Immunol; 1983; 27(7):645-8. PubMed ID: 6195513
[No Abstract] [Full Text] [Related]
13. Poliovirus antigenic sites and vaccines.
Wimmer E; Jameson BA; Emini EA
Nature; 1984 Mar 1-7; 308(5954):19. PubMed ID: 6199673
[No Abstract] [Full Text] [Related]
14. Mapping of the epitopes of poliovirus type 2 in complex with antibodies.
Bannwarth L; Girerd-Chambaz Y; Arteni A; Guigner JM; Ronzon F; Manin C; Vénien-Bryan C
Mol Immunol; 2015 Oct; 67(2 Pt B):233-9. PubMed ID: 26059753
[TBL] [Abstract][Full Text] [Related]
15. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
16. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
Böttiger M
Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
[No Abstract] [Full Text] [Related]
18. [Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis].
Gendon IuZ
Vopr Virusol; 1988; 33(2):137-41. PubMed ID: 2457986
[No Abstract] [Full Text] [Related]
19. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
Shyrobokov VP; Kostenko IH; Nikolaienko IV
Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
[TBL] [Abstract][Full Text] [Related]
20. Neutralization antigenic sites of poliovirus and peptide induction of neutralizing antibodies.
Emini EA; Wimmer E; Jameson BA; Bonin J; Diamond D
Ann Sclavo Collana Monogr; 1984; 1(2):139-46. PubMed ID: 6085885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
